What does Kapelle Apotheek do?

Kapelle Apotheek is a pharmacy in Aartselaar. Private Limited, started on 7 December 2012, 1 establishment.

What is the address of Kapelle Apotheek?

The registered office of Kapelle Apotheek is located at Kapellestraat 90, 2630 Aartselaar.

Is Kapelle Apotheek still active?

Yes. According to the CBE (30 October 2026) Kapelle Apotheek is active, legal situation “Normale toestand”, started on 7 December 2012.

Is Kapelle Apotheek registered on Peppol?

Yes, Kapelle Apotheek is registered on the Peppol network with ID 0208:0501820986.

What is the enterprise number of Kapelle Apotheek?

The enterprise number of Kapelle Apotheek is BE0501820986.

When was Kapelle Apotheek founded?

Kapelle Apotheek was founded on 7 December 2012.

Who are the directors of Kapelle Apotheek?

According to the 2025 annual accounts, the directors of Kapelle Apotheek are: Ortegawynter BV, T&M Pharma BV.

Is Kapelle Apotheek a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 7 December 2012; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Kapelle Apotheek make in 2025?

Kapelle Apotheek posted a profit after taxes of € 40,313 in financial year 2025.

What is the revenue of Kapelle Apotheek?

As a small company, Kapelle Apotheek is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 338,236.

How much does an employee at Kapelle Apotheek earn?

The average wage cost per full-time employee at Kapelle Apotheek was € 56,800 in 2025: staff costs of € 272,549 for 4.8 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Kapelle Apotheek have?

According to the 2025 annual accounts, Kapelle Apotheek has 4.8 full-time equivalents (FTE).

Does Kapelle Apotheek have a website?

Yes, Kapelle Apotheek has a website at kapelleapotheek.be.

Kapelle Apotheek (Private Limited) - Aartselaar

Dossier Kapelle Apotheek, printed on 30 October 2026 from databakkes.be/en/0501820986/kapelle-apotheek. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Kapelle Apotheek from Aartselaar, company number BE0501820986, closed financial year 2025 with a result of € 40,313 after tax. For that financial year Kapelle Apotheek recorded a gross margin of € 338,236 and equity of € 162,003. Compared with financial year 2024, the result moved from € 96,644 to € 40,313. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.

What it is worth Growing

€ 162,003

▲ 33% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 40,313

▼ 58% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 73,807

▲ 49% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 143,403.

People and assets in 2025

Full-time equivalents

4.8

▲ 0.8 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 272,549

▲ 6% vs 2024

€ 56,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 113,979

▲ 185% vs 2024

€ 28,847 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 197,935

▼ 8% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 36,210

▲ 4% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 353,026 Gross margin 2022: € 353,026 First fiscal year in the series	€ 394,443 Gross margin 2023: € 394,443 ▲ 12% vs 2022 (€ 353,026) Favourable step	€ 395,833 Gross margin 2024: € 395,833 Unchanged (€ 394,443) Favourable step	€ 338,236 Gross margin 2025: € 338,236 ▼ 15% vs 2024 (€ 395,833) Unfavourable step	▼ 15%
Profit after taxes	€ 12,932 Profit after taxes 2022: € 12,932 First fiscal year in the series	€ 77,213 Profit after taxes 2023: € 77,213 ▲ € 64,281 vs 2022 (€ 12,932) Favourable step	€ 96,644 Profit after taxes 2024: € 96,644 ▲ 25% vs 2023 (€ 77,213) Favourable step	€ 40,313 Profit after taxes 2025: € 40,313 ▼ 58% vs 2024 (€ 96,644) Unfavourable step	▼ 58%
Equity	€ -52,167 Equity 2022: € -52,167 First fiscal year in the series	€ 25,046 Equity 2023: € 25,046 ▲ € 77,213 vs 2022 (€ -52,167) Favourable step	€ 121,690 Equity 2024: € 121,690 ▲ € 96,644 vs 2023 (€ 25,046) Favourable step	€ 162,003 Equity 2025: € 162,003 ▲ 33% vs 2024 (€ 121,690) Favourable step	▲ 33%
Total debts	€ 379,737 Total debts 2022: € 379,737 First fiscal year in the series	€ 360,745 Total debts 2023: € 360,745 ▼ 5% vs 2022 (€ 379,737) Favourable step	€ 432,153 Total debts 2024: € 432,153 ▲ 20% vs 2023 (€ 360,745) Unfavourable step	€ 394,472 Total debts 2025: € 394,472 ▼ 9% vs 2024 (€ 432,153) Favourable step	▼ 9%
Cash	€ 25,466 Cash 2022: € 25,466 First fiscal year in the series	€ 70,792 Cash 2023: € 70,792 ▲ 178% vs 2022 (€ 25,466) Favourable step	€ 49,480 Cash 2024: € 49,480 ▼ 30% vs 2023 (€ 70,792) Unfavourable step	€ 73,807 Cash 2025: € 73,807 ▲ 49% vs 2024 (€ 49,480) Favourable step	▲ 49%
Retained profit	€ -70,767 Retained profit 2022: € -70,767 First fiscal year in the series	€ 6,446 Retained profit 2023: € 6,446 ▲ € 77,213 vs 2022 (€ -70,767) Favourable step	€ 103,090 Retained profit 2024: € 103,090 ▲ € 96,644 vs 2023 (€ 6,446) Favourable step	€ 143,403 Retained profit 2025: € 143,403 ▲ 39% vs 2024 (€ 103,090) Favourable step	▲ 39%
Bank debt	€ 51,159 Bank debt 2022: € 51,159 First fiscal year in the series	€ 9,808 Bank debt 2023: € 9,808 ▼ 81% vs 2022 (€ 51,159) Favourable step	€ 40,000 Bank debt 2024: € 40,000 ▲ € 30,192 vs 2023 (€ 9,808) Unfavourable step	€ 113,979 Bank debt 2025: € 113,979 ▲ 185% vs 2024 (€ 40,000) Unfavourable step	▲ 185%
Balance sheet total	€ 327,569 Balance sheet total 2022: € 327,569 First fiscal year in the series	€ 385,791 Balance sheet total 2023: € 385,791 ▲ 18% vs 2022 (€ 327,569) Unchanged	€ 553,843 Balance sheet total 2024: € 553,843 ▲ 44% vs 2023 (€ 385,791) Unchanged	€ 556,476 Balance sheet total 2025: € 556,476 Unchanged (€ 553,843) Unchanged
Employees (FTE)	5.1 Employees (FTE) 2022: 5.1 First fiscal year in the series	4 Employees (FTE) 2023: 4 ▼ 1.1 vs 2022 (5.1) Unchanged	4 Employees (FTE) 2024: 4 Unchanged (4) Unchanged	4.8 Employees (FTE) 2025: 4.8 ▲ 0.8 vs 2024 (4) Unchanged	▲ 0.8

Key figures of Kapelle Apotheek, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Kapelle Apotheek?

What happened at Kapelle Apotheek in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 29, 2026 New annual accounts for financial year 2025: profit of € 40,313 (▼ 58% vs 2024). Source: NBB ↗
Jan 1, 2013 New establishment in Aartselaar. KBO
2012 Ortegawynter BV became a director. NBB
2012 T&M Pharma BV became a director. NBB
Dec 7, 2012 Start of the company according to the CBE. KBO